Mount Sinai West Dermatology
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Khattri, Saakshi
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Recruiting
3
1000
Europe, Canada, US
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
07/25
06/26
NCT06092216: Spesolimab in Pyoderma Gangrenosum

Recruiting
2
20
US
Spesolimab
Icahn School of Medicine at Mount Sinai, Boehringer Ingelheim
Pyoderma Gangrenosum
09/25
09/25

Download Options